Home Healthcare Medical Devices Neurorehabilitation Devices Market

Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (Neurorobotics, Brain-Computer Interface, Wearable Devices, Non-Invasive Stimulators, Others), By Applications (Stroke, Parkinson’s Disease, Multiple Sclerosis, Cerebral Palsy, Others), By End-User (Rehabilitation Centers, Hospitals and Clinics, Home Care, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR5399DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Neurorehabilitation Devices Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Neurorobotics
    2. Brain-Computer Interface
    3. Wearable Devices
    4. Non-Invasive Stimulators
    5. Others
  2. Neurorehabilitation Devices Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Stroke
    2. Parkinson’s Disease
    3. Multiple Sclerosis
    4. Cerebral Palsy
    5. Others
  3. Neurorehabilitation Devices Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Rehabilitation Centers
    2. Hospitals and Clinics
    3. Home Care
    4. Others
  4. Regional Neurorehabilitation Devices Market
    1. North America
      1. North America Neurorehabilitation Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
      2. North America Neurorehabilitation Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Stroke
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Cerebral Palsy
        5. Others
      3. North America Neurorehabilitation Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rehabilitation Centers
        2. Hospitals and Clinics
        3. Home Care
        4. Others
      4. U.S.
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      5. Canada
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
    2. Europe
      1. Europe Neurorehabilitation Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
      2. Europe Neurorehabilitation Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Stroke
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Cerebral Palsy
        5. Others
      3. Europe Neurorehabilitation Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rehabilitation Centers
        2. Hospitals and Clinics
        3. Home Care
        4. Others
      4. U.K.
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      5. Germany
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      6. France
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      7. Spain
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      8. Italy
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      9. Russia
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      10. Nordic
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      11. Benelux
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      12. Rest of Europe
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
    3. APAC
      1. APAC Neurorehabilitation Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
      2. APAC Neurorehabilitation Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Stroke
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Cerebral Palsy
        5. Others
      3. APAC Neurorehabilitation Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rehabilitation Centers
        2. Hospitals and Clinics
        3. Home Care
        4. Others
      4. China
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      5. Korea
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      6. Japan
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      7. India
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      8. Australia
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      9. Singapore
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      10. Taiwan
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      11. South East Asia
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      12. Rest of Asia-Pacific
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Neurorehabilitation Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
      2. Middle East and Africa Neurorehabilitation Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Stroke
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Cerebral Palsy
        5. Others
      3. Middle East and Africa Neurorehabilitation Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rehabilitation Centers
        2. Hospitals and Clinics
        3. Home Care
        4. Others
      4. UAE
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      5. Turkey
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      6. Saudi Arabia
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      7. South Africa
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      8. Egypt
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      9. Nigeria
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      10. Rest of MEA
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
    5. LATAM
      1. LATAM Neurorehabilitation Devices Market By Product 2022-2034 (USD MILLION/ Units)
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
      2. LATAM Neurorehabilitation Devices Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Stroke
        2. Parkinson’s Disease
        3. Multiple Sclerosis
        4. Cerebral Palsy
        5. Others
      3. LATAM Neurorehabilitation Devices Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Rehabilitation Centers
        2. Hospitals and Clinics
        3. Home Care
        4. Others
      4. Brazil
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      5. Mexico
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      6. Argentina
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      7. Chile
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      8. Colombia
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
      9. Rest of LATAM
        1. Neurorobotics
        2. Brain-Computer Interface
        3. Wearable Devices
        4. Non-Invasive Stimulators
        5. Others
        6. Stroke
        7. Parkinson’s Disease
        8. Multiple Sclerosis
        9. Cerebral Palsy
        10. Others
        11. Rehabilitation Centers
        12. Hospitals and Clinics
        13. Home Care
        14. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.